The Kenyan capital has experienced a jump in cholera cases, one of the city's top hospitals said on Tuesday, adding that eight of its own staff had been infected by the disease. ...

(Reuters Health) - Older adults who are victims of financial scams may be more likely to develop dementia and Alzheimer's disease than elderly people who don't get tricked by scammers, a small U.S. study suggests. ...

(Reuters Health) - The Food and Drug Administration's new mandatory rules requiring labels on all packaged foods and drinks to indicate the presence of so-called added sugars could have substantial health and cost saving benefits in the United States o... ...

(Reuters Health) - Over a typical 24-hour shift, first year residents training in internal medicine spend just three hours on direct patient care and only 1.8 hours on education, a U.S. study suggests. ...

Amgen Inc on Monday set the U.S. list price for its new Evenity osteoporosis drug at $1,825 a month, or $21,900 for a full 12-month course of injections. ...

(Reuters Health) - People who regularly use cannabis may need more than twice the usual dose of anesthesia for surgery, a U.S. study suggests. ...

Back pain is deemed chronic if it lasts three weeks or more. It will come and go, frequently bringing temporary relief, accompanied closely by frustration .. ...

The number of measles cases worldwide nearly quadrupled in the first quarter of 2019 to 112,163 against the same period last year, the World Health Organization (WHO) said on Monday, citing provisional data. ...

Contract drugmaker Catalent Inc said on Monday it would buy privately held Paragon Bioservices Inc for $1.2 billion in cash, bolstering its capabilities to make gene therapy drugs for its biotech clients. ...

The U.S. Supreme Court on Monday cast aside pharmaceutical company Allergan Plc's unorthodox bid to shield patents from a federal administrative court's review by transferring them to a Native American tribe. ...